UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

The New England journal of medicine, 1994-10, Vol.331 (14), p.896-903

1994

Volltextzugriff (PDF)

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer

Bone marrow transplantation (Basingstoke), 2001-02, Vol.27 (3), p.269-278

2001

Volltextzugriff (PDF)

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer: sequential phase I/II studies

Bone marrow transplantation (Basingstoke), 2001-09, Vol.28 (5), p.447-454

2001

Volltextzugriff (PDF)

The interval between courses of high-dose chemotherapy with stem cell rescue : therapeutic hypotheses

Bone marrow transplantation (Basingstoke), 1999-11, Vol.24 (9), p.939-945

1999

Volltextzugriff (PDF)

Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo

Science (American Association for the Advancement of Science), 1990-03, Vol.247 (4949), p.1457-1461

1990

Volltextzugriff (PDF)

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response

Journal of clinical oncology, 1992-06, Vol.10 (6), p.995-1000

1992

Volltextzugriff (PDF)

Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer

JNCI : Journal of the National Cancer Institute, 1998-08, Vol.90 (16), p.1205-1211

1998

Volltextzugriff (PDF)

A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity

Journal of clinical oncology, 1998-09, Vol.16 (9), p.3137-3147

1998

Volltextzugriff (PDF)

Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia

Cancer research (Chicago, Ill.), 1983-11, Vol.43 (11), p.5601-5607

1983

Volltextzugriff (PDF)

The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity

Clinical cancer research, 1998-09, Vol.4 (9), p.2027-2037

1998

Volltextzugriff (PDF)

Neoadjuvant treatment of stage IIIA non-small cell lung cancer : long-term results

American journal of clinical oncology, 1994-02, Vol.17 (1), p.26-36

1994

Volltextzugriff (PDF)

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer

Journal of clinical oncology, 1995-08, Vol.13 (8), p.2043-2049

1995

Volltextzugriff (PDF)

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

Journal of clinical oncology, 1992-01, Vol.10 (1), p.102-110

1992

Volltextzugriff (PDF)

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

The New England journal of medicine, 1988-09, Vol.319 (10), p.593-598

1988

Volltextzugriff (PDF)

Dose-Intensive Therapy for Limited-Stage Small-Cell Lung Cancer: Long-Term Outcome

Journal of clinical oncology, 1999-04, Vol.17 (4), p.1175-1184

1999

Volltextzugriff (PDF)

Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes

Leukemia, 1993-05, Vol.7 Suppl 1, p.21

1993

Volltextzugriff (PDF)

High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma

Journal of clinical oncology, 1998-03, Vol.16 (3), p.1000-1007

1998

Volltextzugriff (PDF)

Safety and Efficacy of Using a Single Agent or a Phase II Agent Before Instituting Standard Combination Chemotherapy in Previously Untreated Metastatic Breast Cancer Patients: Report of a Randomized Study—Cancer and Leukemia Group B 8642

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1397-1406

1999

Volltextzugriff (PDF)

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study

Journal of clinical oncology, 1994-01, Vol.12 (1), p.37-44

1994

Volltextzugriff (PDF)

Phase II study of topotecan in metastatic non-small-cell lung cancer

Journal of clinical oncology, 1994-02, Vol.12 (2), p.347-352

1994

Volltextzugriff (PDF)

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

JNCI : Journal of the National Cancer Institute, 1988-09, Vol.80 (13), p.1039-1044

1988

Volltextzugriff (PDF)

Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin

Journal of clinical oncology, 1996-11, Vol.14 (11), p.2984-2992

1996

Volltextzugriff (PDF)

Curative cancer chemotherapy

Cancer research (Chicago, Ill.), 1985-12, Vol.45 (12), p.6523-6537

FREI, E. III

1985

Volltextzugriff (PDF)

SQM1 antibody defines a surface membrane antigen in squamous carcinoma of the head and neck

International journal of cancer, 1985-08, Vol.36 (2), p.137-142

1985

Volltextzugriff (PDF)

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support

Journal of clinical oncology, 1989-05, Vol.7 (5), p.651-661

1989

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(134)

Publikationsform

Sprache

Englisch
(159)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Humans
(119)
Science & Technology
(107)
Life Sciences & Biomedicine
(102)
Biological And Medical Sciences
(93)
Medical Sciences
(92)
Oncology
(82)
Antineoplastic Agents
(77)
Pharmacology. Drug Treatments
(76)
Female
(64)
Male
(51)
Chemotherapy
(49)
Adult
(47)
Middle Aged
(43)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(30)
Animals
(29)
Mice
(25)
Aged
(24)
Cyclophosphamide - Administration & Dosage
(24)
Dose-Response Relationship, Drug
(21)
General Aspects
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer

A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer: sequential phase I/II studies

The interval between courses of high-dose chemotherapy with stem cell rescue : therapeutic hypotheses

Tumor Resistance to Alkylating Agents Conferred by Mechanisms Operative Only in Vivo

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response

Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast Cancer

A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: summation dose-intensity

Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia

The relationship between high-dose treatment and combination chemotherapy: the concept of summation dose intensity

Neoadjuvant treatment of stage IIIA non-small cell lung cancer : long-term results

Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

Dose-Intensive Therapy for Limited-Stage Small-Cell Lung Cancer: Long-Term Outcome

Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes

High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma

Safety and Efficacy of Using a Single Agent or a Phase II Agent Before Instituting Standard Combination Chemotherapy in Previously Untreated Metastatic Breast Cancer Patients: Report of a Randomized Study—Cancer and Leukemia Group B 8642

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study

Phase II study of topotecan in metastatic non-small-cell lung cancer

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin

Curative cancer chemotherapy

SQM1 antibody defines a surface membrane antigen in squamous carcinoma of the head and neck

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support

Suchergebnisse filtern